Gram-Positive Cocci

Gram-positive cocci are spherical bacteria that retain crystal violet on Gram staining because of their thick peptidoglycan cell wall. The medically important members are the staphylococci, which cluster in irregular grape-like groups, and the streptococci and enterococci, which form chains or pairs. Together they cause a large fraction of skin, soft-tissue, respiratory, bloodstream, and device-associated infections.

Definition

Gram-positive cocci are round, Gram-positive bacteria comprising chiefly the catalase-positive staphylococci (in clusters) and the catalase-negative streptococci and enterococci (in chains or pairs), several of which are major human pathogens.

Scope

The entry covers the laboratory separation of staphylococci from streptococci (catalase test) and the further subdivision of each (coagulase for staphylococci; haemolysis and Lancefield grouping for streptococci), the principal pathogenic species, their characteristic virulence factors, and their broad clinical correlates. It is a reference and educational overview, not clinical guidance.

Core questions

• How do simple laboratory tests (catalase, coagulase, haemolysis, Lancefield grouping) sort the Gram-positive cocci into clinically meaningful groups?
• What virulence factors distinguish Staphylococcus aureus from coagulase-negative staphylococci and from the streptococci?
• How has methicillin and other resistance changed the clinical significance of these organisms?

Key concepts

• Catalase test (staphylococci vs streptococci)
• Coagulase test (S. aureus vs coagulase-negative staphylococci)
• Haemolysis patterns (alpha, beta, gamma)
• Lancefield grouping of streptococci
• Methicillin-resistant Staphylococcus aureus (MRSA)
• Panton-Valentine leukocidin and other toxins
• Biofilm formation and device-associated infection

Mechanisms

Within the Gram-positive cocci, the catalase test separates the staphylococci (catalase-positive) from the streptococci and enterococci (catalase-negative). Among staphylococci, coagulase distinguishes Staphylococcus aureus from the coagulase-negative species. S. aureus carries an unusually broad armamentarium of surface adhesins, immune-evasion molecules, and secreted toxins, and can acquire methicillin resistance through the mecA-encoded altered penicillin-binding protein (Tong et al., 2015; DeLeo et al., 2010). Coagulase-negative staphylococci are weaker pathogens but excel at forming biofilms on prosthetic surfaces, making them leading causes of device-associated and nosocomial infection (Becker et al., 2014). Streptococci are subdivided by haemolysis and Lancefield carbohydrate antigens, with virulence linked to capsules, M protein, and exotoxins.

Clinical relevance

Gram-positive cocci account for a large share of clinically encountered bacterial infections, from superficial skin lesions to endocarditis, pneumonia, and bloodstream infection, and the laboratory scheme that classifies them maps closely onto these syndromes and onto intrinsic resistance. This entry explains that classifying logic and the evidence behind it as reference material; it does not provide diagnostic thresholds or treatment recommendations.

Epidemiology

Staphylococcus aureus is among the most common causes of bacteraemia, skin and soft-tissue infection, and infective endocarditis worldwide, and meticillin-resistant strains have spread in both healthcare and community settings (Tong et al., 2015; DeLeo et al., 2010). Coagulase-negative staphylococci are leading agents of prosthetic-device and catheter-associated infection (Becker et al., 2014), while streptococci and enterococci contribute substantially to pharyngitis, pneumonia, and healthcare-associated infection.

Evidence & guidelines

Comprehensive reviews in Clinical Microbiology Reviews (Tong et al., 2015; Becker et al., 2014) and The Lancet (DeLeo et al., 2010), together with standard medical-microbiology texts, frame the biology and clinical correlates of this group. Species- and syndrome-specific management is addressed in dedicated clinical guidelines referenced elsewhere, not in this educational entry.

History

The staphylococci and streptococci were among the earliest bacteria associated with human suppurative disease in the nineteenth century, and Rebecca Lancefield's serological grouping of streptococci in the 1930s gave the field a durable classification. The introduction of penicillin and the subsequent emergence of penicillin- and then methicillin-resistant Staphylococcus aureus made these organisms a continuing focus of resistance surveillance.

Key figures

• Steven Y. C. Tong
• Vance G. Fowler
• Frank R. DeLeo
• Karsten Becker

Seminal works

• tong-2015
• becker-2014

Frequently asked questions

What is the quickest way to tell staphylococci from streptococci?

The catalase test: staphylococci are catalase-positive (they bubble when mixed with hydrogen peroxide), whereas streptococci and enterococci are catalase-negative. This single test is the first branch point within the Gram-positive cocci.

Why are coagulase-negative staphylococci important if they are weak pathogens?

They are skin commensals of low intrinsic virulence, but they readily form biofilms on catheters, prosthetic joints, and heart valves, which makes them leading causes of device-associated and healthcare-acquired infection.